RSV

National data shows COVID-19 levels are moderate. In most of the U.S., levels of other respiratory viruses are low, although RSV is ticking up in some southeastern states.

The monoclonal antibody drug prevents the lung infection that puts 58,000 to 80,000 young children in the hospital each year.

At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.

The main reason the surge is ebbing now, pandemic experts suspect, is the significant immunity many people in the U.S. have acquired from prior infections and COVID vaccinations many received.

RSV and the flu appear to be receding in the U.S., but COVID is on the rise, new data suggests, driven by holiday gatherings and an even more transmissible omicron subvariant that has become dominant.